ArticleMedical molecular morphology2016

Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer.

Tetsuyo Maeda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.